Change in Expression of Survivin Caused by Using Oxaliplatin in HCT116 Colon Cancer Cells
about
Double siRNA-targeting of cIAP2 and LIVIN results in synergetic sensitization of HCT-116 cells to oxaliplatin treatmentCombining bevacizumab and chemoradiation in rectal cancer. Translational results of the AXEBeam trial.Antichemosensitizing effect of resveratrol in cotreatment with oxaliplatin in HCT116 colon cancer cell.
P2860
Change in Expression of Survivin Caused by Using Oxaliplatin in HCT116 Colon Cancer Cells
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Change in Expression of Survivin Caused by Using Oxaliplatin in HCT116 Colon Cancer Cells
@ast
Change in Expression of Survivin Caused by Using Oxaliplatin in HCT116 Colon Cancer Cells
@en
Change in Expression of Survivin Caused by Using Oxaliplatin in HCT116 Colon Cancer Cells
@nl
type
label
Change in Expression of Survivin Caused by Using Oxaliplatin in HCT116 Colon Cancer Cells
@ast
Change in Expression of Survivin Caused by Using Oxaliplatin in HCT116 Colon Cancer Cells
@en
Change in Expression of Survivin Caused by Using Oxaliplatin in HCT116 Colon Cancer Cells
@nl
prefLabel
Change in Expression of Survivin Caused by Using Oxaliplatin in HCT116 Colon Cancer Cells
@ast
Change in Expression of Survivin Caused by Using Oxaliplatin in HCT116 Colon Cancer Cells
@en
Change in Expression of Survivin Caused by Using Oxaliplatin in HCT116 Colon Cancer Cells
@nl
P2093
P2860
P1476
Change in Expression of Survivin Caused by Using Oxaliplatin in HCT116 Colon Cancer Cells
@en
P2093
Dong-Guk Park
Jung Won Lee
Won Jun Sohn
P2860
P304
P356
10.3393/JKSC.2010.26.4.246
P577
2010-08-31T00:00:00Z